Investment Banking Associate

Investment Banking Associate

Piper Sandler & Co., New York, NY seeks Investment Banking Associate - Collaborating with senior team members on sell-side M&A and capital raising advisory projects within the Biopharma and Med Tech subsectors to support origination and execution of biopharmaceutical and medical technology transactions. Developing comprehensive financial models and using valuation methodologies to provide financial analysis of investment opportunities and assess potential risks for healthcare companies. Conducting complex valuation analysis and preparing detailed reports on company prospects. Performing in-depth industry and company-specific research in global biopharma and medical technology sectors, including U.S. and European pharmaceutical markets, to provide valuable insights on investment strategies and client recommendations, and advise corporate and financial sponsor clients on strategic acquisitions and divestitures. Preparing investment memorandums and engaging with investors to support capital raising efforts including preparation of investment committee materials, management presentations, and transaction documentation for healthcare mergers and acquisitions, requiring synthesis of scientific, clinical and financial information. Collaborating with senior team members in executing M&A transaction processes, including due diligence, documentation, and negotiation through drafting, reviewing and negotiating engagement letters, confidentiality agreements and purchase agreements related to investment banking transactions. Interacting directly with internal teams, clients, and external stakeholders in the Biopharma subsector to understand their needs, provide updates on project progress, and address any inquiries or concerns throughout the cross-border (transatlantic) transaction execution period. Providing training to personnel on Biopharma and Med Tech healthcare financial models and deal frameworks. Expanding the business franchise within the Biopharma subsector through development of new client relations and interacting with institutional investors by providing up-to-date insights on industry trends, regulatory developments, and market conditions relevant to the industry including evaluation of clinical-stage biopharmaceutical assets (pre-clinical through Phase III), assessment of mechanism of action, therapeutic modality, competitive landscape, and development risk, to support strategic transaction recommendations. Will travel 10% US and/or Int'l. to meet with clients and colleagues.

Requires Bachelor's (or foreign educ. equiv.) Degree in Pharmaceutical Sciences, Finance, Economics or closely related and two (2) yrs. experience in Job Offered or related.

Experience must have included at least 2 yrs. in each of the following:

• Use of financial modelling and valuation methodologies to conduct valuation analyses for healthcare companies, including discounted cash flow (DCF), Leveraged Buyout (LBO), sum of the parts analysis, precedent transactions, comparable companies analyses, in connection with mergers and acquisitions and capital markets transactions; Support origination and execution of biopharmaceutical and medical technology transactions, including buy-side and sell-side mandates, involving analysis of drug development pipelines and medical technology product portfolios as part of transaction due diligence
• Evaluation of clinical-stage biopharmaceutical assets (pre-clinical through Phase III), including assessment of mechanism of action, therapeutic modality, competitive landscape, and development risk, to support strategic transaction recommendations; Performance of cross-border (transatlantic) transaction analysis, including coordination of M&A processes involving the U.S. and European counterparties, and consideration of jurisdiction-specific regulatory, commercial and market factors impacting deal structuring; Preparation of investment committee materials, management presentations, and transaction documentation for healthcare mergers and acquisitions, requiring synthesis of scientific, clinical and financial information; Application of experience in the global biopharma and medical technology sectors, including U.S. and European pharmaceutical markets, to advise corporate and financial sponsor clients on strategic acquisitions and divestitures; and Drafting, reviewing and negotiating engagement letters, confidentiality agreements and purchase agreements related to investment banking transactions.

$135,000/yr.